Once-weekly recombinant human erythropoetin (Epoetin alfa) facilitates optimal ribavirin (RBV) dosing in hepatitis C virus (HCV)-infected patients receiving interferon-α-2b (IFN)/RBV combination therapy

✍ Scribed by Douglas T. Dieterich; Ron Wasserman; Norbert Brau; Tarek I. Hassanein; Edmund J. Bini; Mark Sulkowski

• Book ID: 119429183
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 174 KB
• Volume: 120
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/s0016-5085(08)80317-4